Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGL | P06737 | 2/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | ALB | P02768 | 4/20 | 0.53 |
| ▸ | IL2 | P60568 | 4/20 | 0.53 |
| ▸ | CCKAR | P32238 | 1/20 | 0.53 |
| ▸ | CCKBR | P32239 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3435215 | 0.88 | ACE (0.56) | PYGLGPR84KDM4EALDH1A1PKM | |
| SCHEMBL3434998 | 0.83 | GPR84 (0.45) | PYGLGPR84ALBIL2CCKAR | |
| SCHEMBL21185729 | 0.81 | ALDH1A1 (0.49) | PYGLGPR84ALBIL2ALDH1A1 | |
| SCHEMBL7971407 | 0.79 | CCKAR (0.79) | PYGLALBIL2CCKARCCKBR | |
| SCHEMBL3360046 | 0.78 | GRN (0.51) | GPR84KDM4EALDH1A1 | |
| SCHEMBL21185586 | 0.78 | KDM4E (0.47) | GPR84CCKBRKDM4EALDH1A1 | |
| SCHEMBL28577021 | 0.78 | KDM4E (0.47) | GPR84CCKBRKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL28578292 | 0.77 | KDM4E (0.46) | GPR84CCKBRKDM4EALDH1A1 | |
| SCHEMBL1828604 | 0.77 | PTPN1 (0.56) | PYGLCCKARCCKBRL3MBTL1ACE | |
| SCHEMBL21185465 | 0.77 | ALDH1A1 (0.39) | PYGLGPR84ALBIL2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| US-8236952-B2 | Preparations containing amino acids and orotic acid | Northern Innovations Holding Corp. (CA) | 2012-08-07 | — | — | US | disclosed |
| WO-2009076743-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-25 | — | — | WO | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | IOVATE T. & P. INC. (CA) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156812-A1 | PREPARATIONS CONTAINING AMINO ACIDS AND OROTIC ACID | DDC, ODC1, OTC | PYGL 979/4885GPR84 3114/4885ALB 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.